A Prospective Randomized Trial Comparing Three Different Peripheral Stem Cell Mobilization Regimens in Patients With Symptomatic Multiple Myeloma

Study Status

Open to Enrollment

Study Description

This phase III randomized trial compares three different peripheral stem cell mobilization regimens for patients with multiple myeloma who have received primary induction therapy. The purpose of the study is to compare the efficacy of the three different regimens.

Patients eligible for treatment will be randomly assigned to one of three study arms:

  • Arm A: VELCADE, Cyclophosphamide, and G -CSF
  • Arm B: VELCADE and G-CSF
  • Arm C: Cyclophosphamide and G-CSF


Follow the Myeloma Center online:

Website: http://myelomacenter.org

Blog: http://myelomacenterblog.com

Facebook: Click here to visit the Myloma Facebook Page

Disease Status and/or Stage

Mutliple Myeloma


Weill Cornell Medical College

Key Eligibility

  • Men and women age 18 or older
  • Diagnosed with multiple myeloma
  • Must be within 30 days of completing induction therapy
  • Detailed eligibility reviewed when you contact the study team

Principal Investigator

Ruben Niesvizky, MD


Protocol ID

WCMC IRB #1005011049

Healthy Volunteers


As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.

Contact Us

For general inquiries please e-mail:
Erica Bersin
Manager, Subject Recruitment & Communications
(646) 962-8232

To locate contact information for specific studies, please click the disease areas in the left side navigation and click the study title. There you will find study contact details.

Top of page